CLINICAL_TRIALS
trial_result
· 2020-07-02
Clinical Trial Update: A Single and Multiple-Dose Study of MK-8521 in Healthy and Obese Males (MK-8521-002) [Phase 1]
Summary
Phase 1 study evaluating single and multiple doses of MK-8521 in healthy and obese males with Type 2 Diabetes Mellitus completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2020-07-02